Global Central Nervous System (CNS) Disorders Therapeutics Market is entering a phase of strong expansion, driven by rising disease prevalence, advanced biologics, and continuous innovation across neurosciences. Valued at USD 127.19 billion in 2024, the market is projected to reach USD 168.63 billion by 2032, growing at a CAGR of 4.2%. Robust drug pipelines, breakthrough mechanisms-of... https://www.24lifesciences.com/central-nervous-system-disorders-therapeutics-market-9353